Skip to main content
. Author manuscript; available in PMC: 2019 Nov 14.
Published in final edited form as: Diagn Microbiol Infect Dis. 2011 Feb;69(2):145–152. doi: 10.1016/j.diagmicrobio.2010.10.021

Table 2.

Bronchoscopy indications and subsequent diagnoses of enrolled immunocompetent patients

No. of patients (%)
Indication for bronchoscopy:
Mediastinal/hilar lymphadenopathy 39 (38%)
Pulmonary mass or nodules 37 (36%)
Chronic infiltrate 20 (20%)
Endobronchial lesion/stricture 3 (3%)
Hemoptysis 2 (2%)
Tracheomalacia 1 (1%)
Total 102
Post-bronchoscopy diagnosis:
Primary or metastatic pulmonary lung cancer 52 (51%)
Indeterminate diagnosis or unknown 28 (27%)
Sarcoidosis 14 (14%)
Nonspecific interstitial lung disease or Interstitial lung fibrosis 5 (5%)
Aseptic organizing pneumonia 2 (2%)
Wegener granulomatosis 1 (1%)
Total 102
Other:
Presence of documented COPDa 26 (25%)
Active or recentb smoker 41 (40%)
a

Documentation of COPD obtained from pre-bronchoscopy evaluation in medical record; authors suspect prevalence of COPD in study population to be higher than documented.

b

Recent smoker defined as smoking within the previous 10 years of bronchoscopy.